CEPTARIS THERAPEUTICS

ceptaris-therapeutics-logo

Ceptaris Therapeutics, Inc. is a privately held, specialty pharmaceutical company that is developing a proprietary gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma (CTCL). If approved, Ceptaris' investigational drug would be the first topical mechlorethamine product available to treat the signs and symptoms of this rare cancer.

#SimilarOrganizations #People #Financial #Website #More

CEPTARIS THERAPEUTICS

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
2002-01-01

Address:
Malvern, Pennsylvania, United States

Country:
United States

Website Url:
http://www.ceptaris.com

Total Employee:
11+

Status:
Closed

Contact:
610-975-9290

Total Funding:
64.79 M USD

Technology used in webpage:
Cloudflare DNS CDNS Network


Similar Organizations

adamis-pharmaceuticals-logo

Adamis Pharmaceuticals

Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.

aditum-bio-logo

Aditum Bio

Aditum Bio is an investment fund that specializes in acquiring and developing pharmaceutical assets.

arase-therapeutics-logo

ARase Therapeutics

Arase Therapeutics is a science-focused oncology company developing therapies that modulate cancer-relevant cell signaling pathways.

mediquest-therapeutics-logo

MediQuest Therapeutics

MediQuest Therapeutics is a pharmaceutical company providing topical solutions for inflammatory and infectious diseases.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

validus-cellular-therapeutics-logo

Validus Cellular Therapeutics

Validus Cellular Therapeutics is a developer of therapeutic solutions for treating infectious diseases.

wise-therapeutics-logo

Wise Therapeutics

Wise Therapeutics uses breakthrough neuroscientific research to improve mental health through casual, accessible mobile games.


Current Advisors List

william-hamilton_image

William Hamilton Board of Directors @ Ceptaris Therapeutics
Board_member

albert-cha_image

Albert Cha Board of Directors @ Ceptaris Therapeutics
Board_member

john-doux_image

John Doux Board of Directors @ Ceptaris Therapeutics
Board_member

Current Employees Featured

not_available_image

Jeffrey Shaver
Jeffrey Shaver Vice President of Project Management and Operations @ Ceptaris Therapeutics
Vice President of Project Management and Operations
2011-05-01

not_available_image

John N. Irwin
John N. Irwin Co-Founder @ Ceptaris Therapeutics
Co-Founder
2002-01-01

not_available_image

Tim Henkel
Tim Henkel Executive Vice President, Head of Research and Development @ Ceptaris Therapeutics
Executive Vice President, Head of Research and Development

not_available_image

Doug Gessl
Doug Gessl COO & CFO @ Ceptaris Therapeutics
COO & CFO

not_available_image

Evan Dick
Evan Dick Senior Vice President of Business Development @ Ceptaris Therapeutics
Senior Vice President of Business Development

Founder


not_available_image

John N. Irwin

Investors List

palo-alto-investors_image

Palo Alto Investors

Palo Alto Investors investment in Series D - Ceptaris Therapeutics

bioadvance_image

BioAdvance

BioAdvance investment in Series D - Ceptaris Therapeutics

vivo-capital_image

Vivo Capital

Vivo Capital investment in Series D - Ceptaris Therapeutics

aperture-venture-partners_image

Aperture Venture Partners

Aperture Venture Partners investment in Series D - Ceptaris Therapeutics

osage-partners_image

Osage Venture Partners

Osage Venture Partners investment in Series D - Ceptaris Therapeutics

third-point-ventures_image

Third Point Ventures

Third Point Ventures investment in Series D - Ceptaris Therapeutics

burrill-co_image

Burrill & Company

Burrill & Company investment in Series D - Ceptaris Therapeutics

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Debt Financing - Ceptaris Therapeutics

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Debt Financing - Ceptaris Therapeutics

burrill-co_image

Burrill & Company

Burrill & Company investment in Series D - Ceptaris Therapeutics

Official Site Inspections

http://www.ceptaris.com

  • Host name: 165.150.13.20
  • IP address: 165.150.13.20
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Ceptaris Therapeutics" on Search Engine